# Serum MOTS-c levels remain unchanged in patients with preeclampsia.

> PubMed lists PMID 39469962 in Ginekologia polska as Journal Article, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39469962-mots-c:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-10-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39469962-mots-c/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39469962-mots-c-v1.json
- Content SHA-256: `e5cff2aa2b61052895635af82f9b0076daa52e02a6740d364bf1b3dbae30c300`

## Claims and source pins

### Headline

Serum MOTS-c levels remain unchanged in patients with preeclampsia. ([`pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45`](#source-pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45))

### Summary

PubMed lists PMID 39469962 in Ginekologia polska as Journal Article, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45`](#source-pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45))

### Paragraph 1

PubMed lists PMID 39469962 in Ginekologia polska as Journal Article, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45`](#source-pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45`](#source-pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45))

## Sources

<a id="source-pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45"></a>
- **Serum MOTS-c levels remain unchanged in patients with preeclampsia. · retained source version 1:2024-10-29:current:c6650fed2f452d9e869dea3d74e831e95eaf889d97c3594169be7b428d1f8699** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39469962/) (`pubmed-observation-pmid-39469962-2024-10-29-c6650fed2f45`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Serum MOTS-c levels remain unchanged in patients with preeclampsia." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39469962-mots-c-v1.json SHA-256: e5cff2aa2b61052895635af82f9b0076daa52e02a6740d364bf1b3dbae30c300.

